Toads Are Beating the World's Deadliest Fungus and Offer New Leads to Treat Human Infections
- Gauri Khanna
- 6 minutes ago
- 3 min read
Populations of common midwife toads (Alytes obstetricans) in the Pyrenees have survived outbreaks of Batrachochytrium dendrobatidis, the fungal disease responsible for more vertebrate species extinctions than any other infectious disease in recorded history.
Surviving toads secrete antimicrobial peptides from their skin unusually early, during the tadpole phase, giving them protection precisely when the transition to keratin-bearing adult skin makes them most vulnerable to the fungus.
Researchers identified 1,152 distinct peptides in toad skin secretions, the vast majority previously unknown, compounds that may offer new leads for treating infections in humans at a time when antimicrobial resistance is worsening.
The Most Deadly Fungus on the Planet
Batrachochytrium dendrobatidis, abbreviated to Bd and commonly called chytrid fungus, has earned an unenviable distinction: it has caused more global species extinction events than any other infectious disease. For amphibians, it is almost invariably fatal. The fungus colonises skin, and because frogs and toads absorb oxygen and water through that same porous membrane, an infection effectively suffocates the animal from the outside in.
The Pyrenees were once a cold refuge. High-altitude lakes stayed frozen for half the year, temperatures hostile to the fungus. But nineteen years ago Bd reached the region, and populations of the common midwife toad were nearly wiped out. Climate change, by warming the mountains, has extended the conditions in which the fungus thrives.
And yet a handful of toad populations have held on.
What the Survivors Are Doing Differently
A research team led by scientists from University College London, the Zoological Society of London, and Imperial College London set out to understand why. Their findings, published in Nature Chemical Biology, centre on timing.
The key difference between recovering and declining populations comes down to when the toads' immune defences mature. In the populations that have survived, including those at Ibón de Acherito, Puits d'Arious, and Lac de Lhurs, tadpoles begin secreting antimicrobial peptides from their skin before they complete metamorphosis into adults. In the struggling population at Lac d'Arlet, that early secretion was absent.
The reason timing matters so much is structural. Bd can only colonise skin containing keratin, a protein that is present in adult amphibians but not in tadpoles or larvae. The metamorphic transition, when the animal acquires keratin-rich adult skin, is therefore the window of maximum vulnerability. Toads that arrive at that transition already carrying skin-level chemical defences appear far better placed to survive it.
The team also found that diversity of peptides matters, not just their presence. Tadpoles that developed a higher variety of peptides during their aquatic phase were more likely to survive outbreaks, while those with lower diversity were more susceptible to the disease.
1,152 Peptides, Seven Previously Known
Perhaps the most striking result was the scale of chemical complexity found in toad skin. Across all the populations sampled, the researchers identified 1,152 distinct peptides in the skin secretions, of which only seven had been previously characterised. The sheer breadth of that chemical library was unexpected even to the researchers.
Understanding which of those peptides are genuinely antimicrobial, and how they function against pathogens, is the work still ahead. Lead author Phillip Jervis of ZSL has also flagged the need to understand what determines whether the immune system matures early, whether genetics, temperature, or the presence of predators such as trout, which may accelerate metamorphosis by making tadpoles leave the water sooner.
The potential reaches beyond amphibian conservation. As chemist Alethea Tabor noted, the natural world has a long history of yielding medicines, with penicillin from fungi being the obvious example. These newly catalogued peptides represent potential leads in the search for new antimicrobial compounds at a moment when drug-resistant infections are becoming an acute global problem.
Whether any of these peptides prove clinically useful remains to be seen. The path from toad skin to human medicine is long, and no efficacy data in human models yet exists. But with 1,145 compounds still largely uncharacterised, the catalogue is at least a compelling place to start looking.
